Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xenon Pharmaceuticals Inc (NQ: XENE ) 39.03 +0.42 (+1.09%) Streaming Delayed Price Updated: 11:17 AM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Xenon Pharmaceuticals Inc < Previous 1 2 3 4 Next > XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024 August 08, 2024 XENE stock results show that Xenon Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024 May 09, 2024 XENE stock results show that Xenon Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Earnings Outlook For Xenon Pharmaceuticals February 28, 2024 Via Benzinga 3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition February 21, 2024 Now could be the time to start looking into these biotech stocks as there are imminent approvals on their clinical trials. Via InvestorPlace This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space February 16, 2024 Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset... Via Benzinga 4 Analysts Have This to Say About Xenon Pharmaceuticals December 08, 2023 Via Benzinga Xenon Pharmaceuticals: Q3 Earnings Insights November 08, 2023 Via Benzinga Earnings Outlook For Xenon Pharmaceuticals November 07, 2023 Via Benzinga Expert Ratings for Xenon Pharmaceuticals July 17, 2023 Via Benzinga Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today November 30, 2023 Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares are trading higher by 7.8% to $36.38 Thursday afternoon. The company announced the pricing of its upsized $300 million public offering of 8,461,542... Via Benzinga Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday November 28, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Xenon Pharma's Depression Candidate Shows Positive Signals Of Efficacy, Despite Primary Endpoint Miss: Analyst November 27, 2023 Monday, Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2 proof-of-concept X-NOVA trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20... Via Benzinga Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session November 27, 2023 Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. Via Benzinga Analyst Ratings for Xenon Pharmaceuticals June 15, 2023 Via Benzinga Xenon Pharmaceuticals: Q1 Earnings Insights May 09, 2023 Via Benzinga The Unexpected Depression Drug News That Sent Xenon Pharmaceuticals Soaring November 27, 2023 The company's epilepsy drug also showed promise as a depression treatment. Via Investor's Business Daily What's Going On With Neurology-Focused Xenon Pharmaceuticals' Stock Today? November 27, 2023 Xenon Pharmaceuticals Inc (NASDAQ: XENE) reported topline results from the Phase 2 proof-of-concept X-NOVA trial, which evaluated the clinical efficacy, safety, and tolerability of 10 mg and 20 mg of... Via Benzinga Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday November 27, 2023 U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday. Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company... Via Benzinga Topics Stocks Exposures US Equities Why Is Neurocrine Biosciences Stock Trading Lower Today? November 10, 2023 Thursday, Neurocrine Biosciences Inc (NASDAQ: NBIX) Via Benzinga Where Xenon Pharmaceuticals Stands With Analysts April 25, 2023 Via Benzinga Earnings Scheduled For March 1, 2023 March 01, 2023 Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. Via Benzinga Xenon Pharmaceuticals Earnings Preview February 28, 2023 Via Benzinga Earnings Scheduled For November 8, 2023 November 08, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. Via Benzinga Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value April 25, 2023 Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a Via Benzinga Earnings Scheduled For May 9, 2023 May 09, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023 April 25, 2023 Via Benzinga Benzinga Pro's Top 5 Stocks To Watch For Tuesday, April 25, 2023: GM, SNAP, WEN, XENE, CXAI April 25, 2023 General Motors (GM) - Shares traded about 3% higher Tuesday morning following better-than-expected Q1 earnings and sales and raised guidance. The company said global deliveries of its automobiles Via Benzinga Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric February 02, 2023 The company that remains still has a large pipeline of non-migraine assets. Via Investor's Business Daily Applied UV (NASDAQ: AUVI) Effectively Doubles Its Size Following A Merger That Could Help Shape The Industry – A Brief Look At The Company February 02, 2023 A recent merger between Applied UV Inc. (NASDAQ: AUVI), Puro Lighting (PURO), and LED Supply Co. (LED Supply) seems to have triggered some excitement in the ultraviolet (UV) disinfection equipment... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
